- Sector
- Healthcare
- Industry
- Health Information Services
Highlights
- Market Cap
- $7.36B
- Enterprise Value
- $6.60B
- EPS (TTM)
- ¥38.09
- PE Ratio
- 22.78
- Total Revenue (TTM)
- ¥356.12B
- Gross Profit (TTM)
- ¥219.82B
- EBITDA (TTM)
- ¥73.49B
- Year Range
- $3.97 - $8.85
- ROA (TTM)
- 8.04%
- ROE (TTM)
- 12.55%
- Avg. Volume (1M)
- 132K
- Avg. Volume Value (1M)
- $762.18K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
MTHRY Performance Chart
M3 Inc (MTHRY) is down 17.3% since the beginning of the year. At $6 per share, MTHRY is trading 37.7% below its 52-week high of $9. Investors who bought $1,000 worth of MTHRY shares 5 years ago would now be looking at an investment worth $171.
Loading charts...
Compare this symbol against anything
Returns By Period
M3 Inc (MTHRY) has returned -17.27% so far this year and -10.99% over the past 12 months.
M3 Inc
- 1D
- -6.93%
- 1M
- -2.48%
- 6M
- -9.97%
- YTD
- -17.27%
- 1Y
- -10.99%
- 3Y*
- -20.59%
- 5Y*
- -29.73%
- 10Y*
- —
- ALL TIME*
- -19.63%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
MTHRY Monthly Returns History
Based on dividend-adjusted daily data since Jun 29, 2020, MTHRY's average daily return is -0.05%, while the average monthly return is -1.03%.
Historically, 39% of months were positive and 61% were negative. The best month was Nov 2020 with a return of +38.5%, while the worst month was Apr 2024 at -26.6%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 8 months.
On a daily basis, MTHRY closed higher 47% of trading days. The best single day was Nov 12, 2025 with a return of +14.7%, while the worst single day was Jul 29, 2024 at -10.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -8.11% | -11.44% | -6.09% | -7.47% | -5.73% | 24.32% | -0.18% | -17.27% | |||||
| 2025 | 4.16% | 30.38% | -5.23% | 12.91% | 12.56% | -3.15% | -9.01% | 19.16% | 13.76% | -16.29% | 17.17% | -18.68% | 55.84% |
| 2024 | -4.75% | -7.93% | -0.42% | -26.64% | -8.56% | -0.83% | -3.14% | 3.46% | 3.35% | 2.63% | -5.33% | -9.79% | -47.26% |
| 2023 | 0.90% | -11.47% | 4.85% | -7.38% | -4.61% | -2.35% | 9.33% | -15.89% | -8.54% | -16.26% | 7.87% | -0.12% | -38.69% |
| 2022 | -25.29% | -2.53% | 1.84% | -13.83% | -11.45% | 0.52% | 19.07% | -6.29% | -13.42% | 6.46% | 3.78% | -13.00% | -47.18% |
| 2021 | -7.68% | -10.75% | -13.01% | 2.41% | -5.35% | 9.07% | -10.68% | 2.27% | 11.01% | -20.43% | -9.37% | -4.99% | -47.35% |
Benchmark Metrics
M3 Inc has an annualized alpha of -20.69%, beta of 0.69, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since June 29, 2020.
- This stock participated in 148.46% of S&P 500 Index downside but only 12.65% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.69 may look defensive, but with R2 of 0.07 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -20.69%
- Beta
- 0.69
- R²
- 0.07
- Upside Capture
- 12.65%
- Downside Capture
- 148.46%
Return for Risk
Risk / Return Rank
MTHRY ranks 35 for risk / return — above 35% of stocks peers on PortfoliosLab. Its historical combined result is below the peer median.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for M3 Inc (MTHRY) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MTHRY | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.63 | ||
| Sortino ratioReturn per unit of downside risk | -1.96 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.25 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | -0.20 | 2.00 | -2.20 |
| Martin ratioReturn relative to average drawdown | -0.33 | 8.49 | -8.82 |
Dividends
Dividend History
M3 Inc provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 |
|---|---|---|
| Dividend | $0.00 | $0.07 |
Dividend yield | 0.00% | 1.10% |
Monthly Dividends
The table displays the monthly dividend distributions for M3 Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| 2025 | $0.07 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the M3 Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the M3 Inc was 92.56%, occurring on Aug 9, 2024. The portfolio has not yet recovered.
The current M3 Inc drawdown is 89.35%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-92.56%Aug 2024 | 3y 7mo | — | 5y 6moJan 2021 - now | — |
-13.40%Dec 2020 | 6d | 22d | 28dDec 2020 - Dec 2020 | — |
-12.79%Sep 2020 | 13d | 25d | 1mo 8dSep 2020 - Oct 2020 | — |
-7.76%Oct 2020 | 8d | 12d | 20dOct 2020 - Nov 2020 | — |
-7.24%Jul 2020 | 1d | 6d | 6dJul 2020 - Jul 2020 | — |
Drawdown Indicators
| MTHRY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.56% | -56.78% | -35.78% |
Max Drawdown (1Y)Largest decline over 1 year | -53.45% | -9.10% | -44.35% |
Max Drawdown (3Y)Largest decline over 3 years | -63.99% | -18.90% | -45.09% |
Max Drawdown (5Y)Largest decline over 5 years | -90.33% | -25.43% | -64.90% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -89.35% | -1.58% | -87.77% |
Average DrawdownAverage peak-to-trough decline | -67.66% | -10.70% | -56.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.95% | 2.14% | +29.81% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of M3 Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how M3 Inc is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for MTHRY, comparing it with other companies in the Health Information Services industry. Currently, MTHRY has a P/E ratio of 22.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MTHRY relative to other companies in the Health Information Services industry. Currently, MTHRY has a P/S ratio of 3.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for MTHRY in comparison with other companies in the Health Information Services industry. Currently, MTHRY has a P/B value of 2.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with MTHRY
Add M3 Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with MTHRY